PTC Therapeutics, Inc. (PTCT) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:02.520 Ladies and gentlemen, thank you for standing by. 00:00:02.520 -- 00:00:08.120 Welcome to PTC Therapeutics Second Quarter 2025 Earnings Conference Call. 00:00:08.120 -- 00:00:12.600 All participants are in listen only mode. After the presentation, there will be the question 00:00:12.600 -- 00:00:16.320 and answer session. Today's call is being recorded. 00:00:16.320 -- 00:00:21.100 I would now like to turn the call over to Ellen Cavalleri, Head of Invest Relations. 00:00:21.100 -- 00:00:23.540 Please go ahead. 00:00:25.280 -- 00:00:29.860 Good afternoon, and thank you for joining us to discuss PTC Therapeutics Second Quarter 00:00:29.860 -- 00:00:33.100 2025 Corporate Update and Financial Results. 00:00:33.100 -- 00:00:35.720 I'm joined today by our Chief Executive Officer, Dr. 00:00:35.720 -- 00:00:40.380 Matthew Klein, our Chief Business Officer, Eric Powell, and our Chief Financial Officer, 00:00:40.380 -- 00:00:44.520 Pierre Gravier. Today's call will include forward-looking statements based on our current 00:00:44.520 -- 00:00:48.880 expectations. These statements are subject to certain risks and uncertainties, and actual 00:00:48.880 -- 00:00:53.620 results may differ materially. Please review the slide posted on our Investor Relations 00:00:53.620 -- 00:00:57.480 website in conjunction with the call, which contains information about our forward-looking 00:00:57.480 -- 00:01:02.640 statements and our most recent quarterly report on Form 10Q and annual report on Form 00:01:02.640 -- 00:01:07.740 10K filed with the SEC, as well as our other SEC filings for 00:01:07.740 -- 00:01:11.500 a detailed description of applicable risks and uncertainties that could cause our actual 00:01:11.500 -- 00:01:16.020 performance and results to d...